Afessa, B, Abdulai, RM, Kremers, WK, et al. 2012. Risk factors and outcome of pulmonary complications after autologous hematopoietic stem cell transplant. Chest 141: 442–450.CrossRefGoogle ScholarPubMed

Armenian, SH, Sun, CL, Francisco, L, et al. 2008. Late congestive heart failure after hematopoietic cell transplantation. J Clin Oncol 26: 5537–5543.CrossRefGoogle ScholarPubMed

Armenian, SH, Sun, CL, Shannon, T, et al. 2011. Incidence and predictors of congestive heart failure after autologous hematopoietic cell transplantation. Blood 118: 6023–6029.CrossRefGoogle ScholarPubMed

Bai, JP, Lesko, LJ, & Burckart, GJ. 2010. Understanding the genetic basis for adverse drug effects: the calcineurin inhibitors. Pharmacotherapy 30: 195–209.CrossRefGoogle ScholarPubMed

Batts, ED & Lazarus, HM. 2007. Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?Bone Marrow Transplant 40: 709–719.CrossRefGoogle ScholarPubMed

Bearman, SI, Anderson, GL, Mori, M, et al. 1993. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation. J Clin Oncol 11: 1729–1736.CrossRefGoogle ScholarPubMed

Bhatia, S, Francisco, L, Carter, A, et al. 2007. Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. Blood 110: 3784–3792.CrossRefGoogle ScholarPubMed

Brennan, BM & Shalet, SM. 2002. Endocrine late effects after bone marrow transplant. Br J Haematol 118: 58–66.CrossRefGoogle ScholarPubMed

Carreras, E, Díaz-Beyá, M, Rosiñol, L, et al. 2011. The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant 17: 1713–1720.CrossRefGoogle ScholarPubMed

Choi, CM, Schmaier, AH, Snell, MR, et al. 2009. Thrombotic microangiopathy in haematopoietic stem cell transplantation: diagnosis and treatment. Drugs 69: 183–198.CrossRefGoogle ScholarPubMed

Consortium: National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines. 2012. Biol Blood Marrow Transplant 18: 334–347.

Corbacioglu, S, Cesaro, S, Faraci, M, et al. 2012. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial. Lancet 379: 1301–1309.CrossRefGoogle ScholarPubMed

Couriel, D, Carpenter, PA, Cutler, C, et al. 2006. Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary therapy and supportive care working group report. Biol Blood Marrow Transplant 12: 375–396.CrossRefGoogle ScholarPubMed

de Padua Silva, L, Patah, PA, Saliba, RM, et al. 2010. Hemorrhagic cystitis after allogeneic hematopoietic stem cell transplants is the complex result of BK virus infection, preparative regimen intensity and donor type. Haematologica 95: 1183–1190.CrossRefGoogle Scholar

De Pasquale, MD, Mastronuzzi, A, De Vito, R, et al. 2012. Unmanipulated donor lymphocytes for EBV-related PTLD after T-cell depleted HLA-haploidentical transplantation. Pediatrics 129: e189–194.CrossRefGoogle ScholarPubMed

Dropulic, LK & Jones, RJ. 2008. Polyomavirus BK infection in blood and marrow transplant recipients. Bone Marrow Transplant 41: 11–18.CrossRefGoogle ScholarPubMed

Filipovich, AH, Weisdorf, D, Pavletic, S, et al. 2005. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 11: 945–956.CrossRefGoogle ScholarPubMed

Fukuda, T, Hackman, RC, Guthrie, KA, et al. 2003. Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation. Blood 102: 2777–2785.CrossRefGoogle ScholarPubMed

Grauer, O, Wolff, D, Bertz, H, et al. 2010. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on clinical practice in chronic graft-versus-host disease. Brain 133: 2852–2865.CrossRefGoogle ScholarPubMed

Guglin, M, Aljayeh, M, Saleemuddin, S, et al. 2009. Introducing a new entity: chemotherapy-induced arrhythmia. Europace 11: 1579–1586.CrossRefGoogle ScholarPubMed

Haines, HL, Laskin, BL, Goebel, J, et al. 2011. Blood, and not urine, BK viral load predicts renal outcome in children with hemorrhagic cystitis following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 17: 1512–1519.CrossRefGoogle ScholarPubMed

Hammond, C, Abrams, JR, & Syryala, KL. 2007. Fertility and risk factors elevated infertility concern in 10-year hematopoietic cell transplant survivors and case-matched controls. J Clin Oncol 25: 3511–3517.CrossRefGoogle ScholarPubMed

Hassan, Z. 2011. Management of refractory hemorrhagic cystitis following hematopoietic stem cell transplantation in children. Pediatr Transplant 15: 348–361.CrossRefGoogle ScholarPubMed

Heslop, HE. 2009. How I treat EBV lymphoproliferation. Blood 114: 4002–4008.CrossRefGoogle Scholar

Hildebrandt, GC, Fazekas, T, Lawitschka, A, et al. 2011. Diagnosis and treatment of pulmonary chronic GVHD: report from the consensus conference on clinical practice in chronic GVHD. Bone Marrow Transplant 46: 1283–1295.CrossRefGoogle ScholarPubMed

Ho, VT, Cutler, C, Carter, S, et al. 2005. Blood and marrow transplant clinical trials network toxicity committee consensus summary. Biol Blood Marrow Transplant 11: 571–575.CrossRefGoogle ScholarPubMed

Hoorn, EJ, Walsh, SB, McCormick, JA, et al. 2011. The calcineurin inhibitor tacrolimus activates the renal sodium chloride cotransporter to cause hypertension. Nat Med 17: 1304–1309.CrossRefGoogle ScholarPubMed

Kida, A & McDonald, GB. 2012. Gastrointestinal, hepatobiliary, pancreatic, and iron-related diseases in long-term survivors of allogeneic hematopoietic stem cell transplantation. Semin Hematol 49: 43–58.CrossRefGoogle Scholar

Klein, IH, Abrahams, AC, van Ede, T, et al. 2010. Differential effects of acute and sustained cyclosporine and tacrolimus on sympathetic nerve activity. J Hypertens 28: 1928–1934.CrossRefGoogle ScholarPubMed

Kojouri, K & George, JN. 2007. Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation. Curr Opin Oncol 19: 148–154.CrossRefGoogle ScholarPubMed

Lakshminarayanan, S, Sahdev, I, Goyal, M, et al. 2010. Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution. Pediatr Transplant 14: 618–621.CrossRefGoogle Scholar

Laskin, BL, Goebel, J, Davies, SM, et al. 2011. Small vessels, big trouble in the kidneys and beyond: hematopoietic stem cell transplantation-associated thrombotic microangiopathy. Blood 118: 1452–1462.CrossRefGoogle ScholarPubMed

Lee, SJ, Schover, LR, Partridge, AH, et al. 2006. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24: 2917–2931.CrossRefGoogle Scholar

Leung, AY, Yuen, KY, & Kwong, YL. 2005. Polyoma, BKvirus and haemorrhagic cystitis in haematopoietic stem cell transplantation: a changing paradigm. Bone Marrow Transplant 36: 929–937.CrossRefGoogle ScholarPubMed

Litzow, MR, Tarima, S, Pérez, WS, et al. 2010. Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia. Blood 115: 1850–1857.CrossRefGoogle ScholarPubMed

Liu, J, Malhotra, R, Voltarelli, J, et al. 2008. Ovarian recovery after stem cell transplantation. Bone Marrow Transplant 41: 275–278.CrossRefGoogle ScholarPubMed

Majhail, NS. 2011. Secondary cancers following allogeneic haematopoietic cell transplantation in adults. Br J Haematol 154: 301–310.CrossRefGoogle ScholarPubMed

Majhail, NS, Lazarus, HM, Burns, LJ. 2010. Iron overload in hematopoietic cell transplantation. Bone Marrow Transplant 41: 997–1003.CrossRefGoogle Scholar

Majhail, NS, Rizzo, JD, Lee, SJ, et al. 2012. Recommended screening and preventive practices for long term survivors after hematopoietic stem cell transplantation. Biol Bone Marrow Transplant 18: 348–371.CrossRefGoogle Scholar

Maradei, SC, Maiolino, A, de Azevedo, AM, et al. 2009. Serum ferritin as risk factor for sinusoidal obstruction syndrome of the liver undergoing hematopoietic stem cell transplantation. Blood 114: 1270–1275.CrossRefGoogle ScholarPubMed

Mattson, J, Ringdén, O, & Storb, R. 2008. Graft failure after hematopoietic cell transplantation. Biol Blood Marrow Transplant 14: S165–S170.CrossRefGoogle Scholar

Miller, AN, Glode, A, Hogan, KR, et al. 2011. Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transplant 17: 1176–1181.CrossRefGoogle ScholarPubMed

Panoskaltsis-Mortari, A, Griese, M, Madtes, DK, et al. 2011. An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med 183: 1262–1279.CrossRefGoogle ScholarPubMed

Parsons, SK, Phipps, S, Sung, L, et al. 2012. NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: health-related quality of life, functional, and neurocognitive outcomes. Biol Blood Marrow Transplant 18: 162–171.CrossRefGoogle ScholarPubMed

Pavletic, SZ, Martin, P, Lee, SJ, et al. 2006. Measuring therapeutic response in chronic graft-versus-host disease: National Institute of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response criteria working group report. Biol Blood Marrow Transpl 12: 252–266.CrossRefGoogle ScholarPubMed

Pullarkat, V.2010. Iron overload in patients undergoing hematopoietic stem cell transplantation. Adv Hematol 2010; pii: 345756.CrossRefGoogle ScholarPubMed

Pullarkat, V, Blanchard, S, Tegtmeier, B, et al. 2008. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Bone Marrow Transplant 42: 799–805.CrossRefGoogle ScholarPubMed

Pulsipher, MA, Skinner, R, McDonald, GB, et al. 2008. Progressive declines in neurocognitive function among survivors of hematopoietic stem cell transplantation for pediatric hematologic malignancies. J Pediatr Hematol Oncol 30: 411–418.Google Scholar

Pulsipher, MA, Skinner, R, McDonald, GB, et al. 2012. National Cancer Institute, National Heart, Lung and Blood Institute/Pediatric Blood and Marrow Transplantation Consortium First International Consensus Conference on late effects after pediatric hematopoietic cell transplantation: the need for pediatric-specific long-term follow-up guidelines. Biol Blood Marrow Transplant 18: 334–347.CrossRefGoogle ScholarPubMed

Richardson, PG, Soiffer, RJ, Antin, JH, et al. 2010. Defibrotide for the treatment of severe hepatic veno-occlusive disease and multiorgan failure after stem cell transplantation: a multicenter, randomized, dose-finding trial. Biol Blood Marrow Transplant 16: 1005–1017.CrossRefGoogle ScholarPubMed

Rizzo, JD, Curtis, RE, Socié, G, et al. 2009. Solid cancers after allogeneic hematopoietic cell transplantation. Blood 113: 1175–1183.CrossRefGoogle ScholarPubMed

Ruutu, T, Barosi, G, Benjamin, RJ, et al. 2007. Diagnostic criteria for hematopoietic stem cell transplant associated microangiopathy: results of a consensus process by an international working group. Haematologica 92: 95–100.CrossRefGoogle ScholarPubMed

Sakaguchi, H, Takahashi, Y, Watanabe, N, et al. 2011. Incidence, clinical features, and risk factors of idiopathic pneumonia syndrome following hematopoietic stem cell transplantation in children. Pediatr Blood Cancer 58: 780–784.CrossRefGoogle ScholarPubMed

Sanders, JE, Guthrie, KA, Hoffmeister, PA, et al. 2005. Final adult height of patients who received hematopoietic cell transplantation in childhood. Blood 105: 1348–1354.Google Scholar

Savani, BN, Griffith, ML, Jagasia, S, et al. 2011. How I treat late effects in adults after allogeneic stem cell transplantation. Blood 117: 3002–3009.CrossRefGoogle Scholar

Schlatzer, DM, Dazard, JE, Ewing, RM, et al. 2012. Human biomarker discovery and predictive models for disease progression for idiopathic pneumonia syndrome following allogeneic stem cell transplantation. Mol Cell Proteomics [Epub ahead of print].

Siegal, D, Keller, A, Xu, W, et al. 2007. Central nervous system complications after allogeneic stem cell transplantation: Incidence, manifestations, and clinical significance. Biol Blood Marrow Transplant 13: 1369–1379.CrossRefGoogle ScholarPubMed

Socié, G, Baker, KS, Bhatia, S, et al. 2012. Subsequent malignant neoplasms after hematopoietic cell transplantation. Biol Blood Marrow Transplant 18: S139–S150.CrossRefGoogle ScholarPubMed

Stavrou, E & Lazarus, HM. 2010. Thrombotic microangiopathy in haematopoietic cell transplantation: an update. Mediterr J Hematol Infect Dis 2 : e2010033.CrossRefGoogle ScholarPubMed

Tichelli, A, Bucher, C, Rovó, A, et al. 2007. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 110: 3463–3471.CrossRefGoogle ScholarPubMed

Tizon, R, Frey, N, Heitjan, DF, et al. 2012. High-dose corticosteroids with or without etanercept for the treatment of idiopathic pneumonia syndrome after allo-SCT. Bone Marrow Transplant 47: 1332–1337.

Tsuboi, K, Kishi, K, Ohmachi, K, et al. 2003.Multivariate analysis of risk factors for hemorrhagic cystitis after hematopoietic stem cell transplantation. Bone Marrow Transplant 32: 903–907.CrossRefGoogle ScholarPubMed

Wei, J, Xiao, Y, Yu, X, et al. 2010. Early onset of syndrome of inappropriate antidiuretic hormone secretion (SIADH) after allogeneic haematopoietic stem cell transplantation: case report and review of the literature. J Int Med Res 38: 705–710.CrossRefGoogle ScholarPubMed

Yanik, GA, Ho, VT, White, ES, et al. 2008. The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Blood 112: 3073–3081.Google Scholar